from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2313c/-

LFCtreatmentdescriptionclass of inhibitor

-0.479

Amikacinug/mL Amikacintranslation

-0.802

Cap5-10ug/mL Capreomycintranslation

-0.634

Rox10-50 ug/mL Roxithromycintranslation

-0.799

SM2-5 ug/mL Streptomycintranslation

-1.157

Tet5-10 ug/mL Tetracyclinetranslation

0.691

Rif0.2-5ug/mL Rifampicintranscription

0.303

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.100

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.138

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.184

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.698

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.631

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.132

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.315

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.212

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.471

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.402

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.681

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.285

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.333

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.827

KCN5-20 ug/mL Potassium cyaniderespiration

-0.325

NaN30.2-2 mM Sodium aziderespiration

-0.145

Nigericin50 uM Nigericinrespiration

0.506

TRC10-150 ug/mL Triclosanrespiration

0.529

TRZ10-25 ug/mL Thioridazinerespiration

0.648

Valinomycin0.5-10 uM Valinomycinrespiration

-2.305

ZnSO42 mM ZnSO4respiration

0.823

menadione6-10 ug/mL Menadionerespiration

-0.077

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.683

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.145

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.258

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.533

NRP_1Non-replicating persistence stage 1dosRassociated

-0.030

Amp0.2mg/mL AmpicillincellWall

-0.938

Cephalexin20-100 ug/mL CephalexincellWall

-0.617

Cerulenin0.32-5 ug/mL CerulenincellWall

0.891

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.216

EMB10-20 ug/mL EthambutolcellWall

-1.306

Eta12-40 ug/mL EthionamidecellWall

-1.840

INH0.2-0.4 ug/mL IsoniazidcellWall

0.649

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.188

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.672

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.528

BZA0.12 mg/mL BenzamidearomaticAmides

0.325

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.382

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.430

H2O24 mM hydrogen peroxideDNAdamaging

-0.369

Levo10 ug/mL LevofloxacinDNAdamaging

0.180

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.596

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.463

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.534

UVUV-irradiationDNAdamaging

0.968

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.330

Antimycin12.5-50 ug/mL Antimycin A?

1.186

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.247

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.277

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.441

PA8240.2-2 ug/mL PA-824?

-0.466

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.850

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.813

Verapamil50 uM Verapamil?

0.633

mercaptoethanol2 mM 2-Mercaptoethanol?

0.115

methoxatin10-20 ug/mL Methoxatin?